Change date, as the article has been updated

ljl-covid · Apr 30, 2020 · 7b6799f · 7b6799f
1 parent de05682
commit 7b6799f
Showing 1 changed file with 1 addition and 1 deletion.
diff --git a/README.md b/README.md
@@ -170,7 +170,7 @@ You can read and follow [this self-triage tool](https://www.statnews.com/2020/03
 
 * [SARS-CoV-2 Vaccines: Status Report](https://www.cell.com/immunity/pdf/S1074-7613(20)30120-5.pdf), published on Cell on April 14, also covers therapeutics and has a summary table of vaccine types being investigated and their main characteristics on page 386
 * [oronavirus Vaccine Prospects](https://blogs.sciencemag.org/pipeline/archives/2020/04/15/coronavirus-vaccine-prospects), an April 15 In The Pipeline article
-* [A Close Look at the Frontrunning Coronavirus Vaccines As of April 23](https://blogs.sciencemag.org/pipeline/archives/2020/04/23/a-close-look-at-the-frontrunning-coronavirus-vaccines-as-of-april-23), another In The Pipeline article
+* [A Close Look at the Frontrunning Coronavirus Vaccines As of April 28](https://blogs.sciencemag.org/pipeline/archives/2020/04/23/a-close-look-at-the-frontrunning-coronavirus-vaccines-as-of-april-23), another In The Pipeline article
 * [Covid-19 Biologic Therapies Reviewed](https://blogs.sciencemag.org/pipeline/archives/2020/03/09/covid-19-biologic-therapies-reviewed), an older article covering both treatments based on antibodies isolated from plasma and vaccine prospects
 * [Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications](https://www.medrxiv.org/content/10.1101/2020.03.30.20047365v2), a preprint, and [Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019](https://www.ncbi.nlm.nih.gov/pubmed/32221519) try to delineate antibody production in COVID-19 patients
 * [Antibody surveys suggesting vast undercount of coronavirus infections may be unreliable](https://www.sciencemag.org/news/2020/04/antibody-surveys-suggesting-vast-undercount-coronavirus-infections-may-be-unreliable), a ScienceMag article critical of the methodologies and conclusions of a few of the large-sample antibody assays done recently around the world, while also describing them to the extent it's possible (since a few gave their results to the press before publishing papers)